Cathay Biotech: Accumulated over 10 million spent on share repurchase for incentives

Zhitong
2025.10.09 07:35

Shanghai Cathay Biotech Co., Ltd. announced the progress of its share repurchase. The repurchase was proposed by the original controlling shareholder and was approved by the board of directors on October 21, 2024. The implementation period is from October 21, 2024, to October 20, 2025, with an expected repurchase amount of 10 million to 20 million yuan, intended for the employee stock ownership plan or equity incentive. As of September 30, 2025, the company has cumulatively repurchased 230,366 shares, accounting for 0.0319% of the total share capital, with a cumulative repurchase amount of 10,497,716.71 yuan, and the actual repurchase price range is 44.08 yuan/share - 53.40 yuan/share. The company will continue to promote the repurchase in accordance with regulations and disclose information in a timely manner

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.